Details of the Drug

General Information of Drug (ID: DMHVW92)

• Drug Name: NWP-09

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 3	[1]

• Cross-matching ID: TTD ID: D0TY5K

References

• [1] ClinicalTrials.gov (NCT01654250) NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD). U.S. National Institutes of Health.